
IDEXX Laboratories (IDXX) Stock Forecast & Price Target
IDEXX Laboratories (IDXX) Analyst Ratings
Bulls say
IDEXX Laboratories is positioned for long-term success due to its leadership in the animal health diagnostics and software market, which accounts for majority of its revenue. With an annual growth rate of 11% and impressive profit margins over the past 5 years, the company has a strong track record of operational performance. Its solid recurring revenue and customer retention rates further highlight its market relevance and value-add to clinics. Despite facing some recent market challenges, IDEXX's future growth prospects remain strong, driven by factors such as pet ownership trends, innovation in diagnostics, and an expanding customer base.
Bears say
IDEXX Laboratories is a global leader in developing, manufacturing, and distributing diagnostic products and services for companion animals and livestock. While IDXX has a diversified portfolio and a dominant position in the animal health diagnostics market, its growth outlook may be impacted by a decline in vet office visits and increasing competition from larger animal health companies. Additionally, customer base consolidation and potential supply chain disruptions could negatively affect IDXX's business. However, the company is well-positioned to benefit from the growing importance of regular/wellness checkups and preventive diagnostics, as well as the humanization of pets trend among younger, digitally-native pet owners.
This aggregate rating is based on analysts' research of IDEXX Laboratories and is not a guaranteed prediction by Public.com or investment advice.
IDEXX Laboratories (IDXX) Analyst Forecast & Price Prediction
Start investing in IDEXX Laboratories (IDXX)
Order type
Buy in
Order amount
Est. shares
0 shares